Clinical trials
catalyst calendar across sponsors →Studies where BFLY is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
1 observational
Held by 13 tracked-famous managers (GLENVIEW CAPITAL MANAGEMENT, LLC, D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, POLEN CAPITAL MANAGEMENT LLC, +8 more) · FINRA short interest 4.3 days to cover (settled 2026-07-31) · insider 90d: 0 buys / 3 sells · government filings 180d: none disclosed
| Study | Phase | Status | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|
| Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility StudyNCT05594940observationalPatients Image Quality | — | Terminatedsponsor's stated reason: Data Analysis | Congestive Heart Failure | 22 | 2024-02-23actual | 2024-02-26 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19